Form 4 for HCA HCA Healthcare
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-13 · accession 0001193125-26-057701 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-18 | 2026-02-13 | HCA | McAlevey Michael R | EVP, Chief Legal, Admin Off | F - Tax | $540.29 | -3,306 | 10.5K | -24% | -$1.79M |
| D | 2026-02-18 | 2026-02-13 | HCA | McAlevey Michael R | EVP, Chief Legal, Admin Off | M - OptEx | $236.61 | +5,000 | 13.9K | +56% | +$1.18M |
| D | 2026-02-18 | 2026-02-18 | HCA | McAlevey Michael R | EVP, Chief Legal, Admin Off | S - Sale+OE | $533.37 | -1,694 | 8,853 | -16% | -$903.5K |
| D | 2026-02-18 | 2026-02-13 | HCA | McAlevey Michael R | EVP, Chief Legal, Admin Off | M - OptEx | $0.00 | -5,000 | 8,860 | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-13 | F | D | 3,306 | $540.29 | 10,547 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-13 | M | A | 5,000 | $236.61 | 13,853 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-18 | S | D | 1,694 | $533.37 | 8,853 | D | — | — | |
| 4 | Derivative | Stock Appreciation Right | 2026-02-13 | M | D | 5,000 | $0.00 | 8,860 | D | $236.61 · — to 2032-01-28 | 5,000 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023. |